Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children-Reference-Cited by-同舟云学术

Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children

Published:2013-08-08 Issue:8 Volume:9 Page:1691-1697
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yetman Robert J,Shepard Julie S,Duke Anton,Stek Jon E,Petrecz Maria,Klopfer Stephanie O,Kuter Barbara J,Schödel Florian P,Lee Andrew W

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.24873

Reference11 articles.

1. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial

2. An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults: safety, tolerability, and immunogenicity

3. A randomized study of a flexible booster dosing regimen of VAQTA® in adults: safety, tolerability, and immunogenicity

4. A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA®, Merck) in children and adults

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do vaccines cause epilepsy? Review of cases in the National Vaccine Injury Compensation Program;Epilepsia;2023-12-28

2. Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial;Clinical Microbiology and Infection;2023-12

3. Does co-administration of vaccines interfere with immune responses? The jury is still out;Clinical Microbiology and Infection;2023-12

4. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context;Expert Review of Vaccines;2023-09-07

5. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country;Vaccine;2023-02